MDMartin Duckheim

Martin Duckheim

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Martin Duckheim has a total of 20 co-authors. Here are the top co-authors by number of shared publications:

  • Jürgen Schreieck

    Innere Medizin III, Department of Cardiology and Angiology, Eberhard Karls Universität Tübingen, Tübingen, Germany

    2 shared publications
  • Meinrad Gawaz

    Innere Medizin III, Department of Cardiology and Angiology, Eberhard-Karls-Universität Tübingen, Tübingen, Germany

    2 shared publications
  • Balram Neupane

    Department of Cardiology University Hospital RWTH Aachen

    1 shared publication
  • Carole Maleck

    Department of Cardiology and Cardiovascular Diseases, Eberhard Karls University, Tübingen, Germany

    1 shared publication
  • Christian Eick

    Innere Medizin III, Department of Cardiology and Angiology, Eberhard-Karls-Universität Tübingen, Tübingen, Germany

    1 shared publication
  • Christian Scheckenbach

    Department of Cardiology and Cardiovascular Diseases, Eberhard Karls University, Tübingen, Germany

    1 shared publication

Latest Publications

  • COVID-19 and Cardiac Arrhythmias

    by Martin Duckheim, Jürgen Schreieck

    Since the coronavirus disease (COVID-19) pandemic spread unrelentingly all over the world, millions of cases have been reported. Despite a high number of asymptomatic cases, the course of the disease can be serious or even fatal. The affection of the myocardium, called myocardial injury, is caused by multiple triggers. The occurrence of cardiac arrhythmias in COVID-19 patients with myocardial involvement and a critical course is common. In this review, potential mechanisms, incidence, and treatment options for cardiac arrhythmias in COVID-19 patients will be provided by performing a literature research in MESH database and the National Library of Medicine. Common cardiac arrhythmias in COVID-19 patients were sinus tachycardia, atrial fibrillation (AF), ventricular tachycardia (VT), ventricular fibrillation (VF), atrioventricular block, sinusoidal block or QTc prolongation. AF was the most common heart rhythm disorder. About 10% of COVID-19 patients develop new-onset AF and 23 to 33% showed recurrence of AF in patients with known AF. One retrospective trial revealed the incidence of VT or VF to be 5.9% in hospitalized patients. Both AF and VT are clearly associated with worse outcome. Several mechanisms such as hypoxia, myocarditis, myocardial ischemia, or abnormal host immune response, which induce cardiac arrhythmias, have been described. The effect of QT-prolonging drugs in inducing cardiac arrhythmias has become mitigated as these medications are no longer recommended. Acute management of cardiac arrhythmias in COVID-19 patients is affected by the reduction of exposure of health care personnel. More prospective data are desirable to better understand pathophysiology and consecutively adapt management.


  • Open Access

    Deceleration capacity for rapid risk stratification in patients suffering from acute ischemic stroke

    by Martin Duckheim, Martin Gaebler, Lars Mizera, Juergen Schreieck, Sven Poli, Ulf Ziemann, Meinrad Gawaz, Christine S Meyer-Zuern, Christian Eick

    Deceleration capacitiy for rapid risk stratification in stroke patients Cerebral ischemia is a major cause of neurologic deficit and patients suffering from ischemic stroke bear a relevant risk of mortality. Identifying stroke patients at high mortality risk is of crucial clinical relevance. Deceleration capacity of heart rate (DC) as a parameter of cardiac autonomic function is an excellent predictor of mortality in myocardial infarction and heart failure patients. The aim of our study was to evaluate whether DC provides prognostic information regarding mortality risk in patients with acute ischemic stroke. From September 2015 to March 2018 we prospectively enrolled consecutive patients presenting at the Stroke Unit of our university hospital with acute ischemic stroke who were in sinus rhythm. In these patients 24 hours-Holter-ECG recordings and evaluation of National Institute of Health Stroke Scale (NIHSS) were performed. DC was calculated according to a previously published algorithm. Primary endpoint was intrahospital mortality. Eight hundred seventy eight stroke patients were included in the study. Intrahospital mortality was 2.8% (25 patients). Both DC and NIHSS were significantly different between non-survivors and survivors (Mean ± SD: DC: 4.1 ± 2.8 ms vs 6.3 ± 3.3 ms, P < .001) (NIHSS: 7.6 ± 7.1 vs 4.3 ± 5.5, P = .02). DC achieved an area under the curve value (AUC) of 0.708 for predicting intrahospital mortality, while the AUC value of NIHSS was 0.641. In a binary logistic regression analysis, DC, NIHSS and age were independent predictors for intrahospital mortality (DC: HR CI 95%: 0.88 (0.79–0.97); P = .01; NIHSS: HR CI 95%: 1.08 (1.02–1.15); P = .01; Age: HR CI 95%: 1.07 (1.02–1.11); P = .004. The combination of NIHSS, age and DC in a prediction model led to a significant improvement of the AUC, which was 0.757 (P < .001, incremental development index [IDI] 95% CI: 0.037 (0.018–0.057)), compared to the individual risk parameters. Our study demonstrated that DC is suitable for both objective and independent risk stratification in patients suffering from ischemic stroke. The application of a prediction model combining NIHSS, age and DC is superior to the single markers in identifying patients at high mortality risk.


  • Polypharmazie – Medikamente und QTc-Zeit. Was ist zu beachten?

    by Martin Duckheim, Meinrad Gawaz

    Das erworbene Long-QT-Syndrom ist eine seltene Erkrankung. Allerdings ist die Inzidenz bei Patienten mit Polypharmazie deutlich erhöht. Das Risiko für QTc-Verlängerung als auch für Torsade-de-Pointes-Tachykardien wird durch die gleichzeitige Einnahme mehrerer QTc-Zeit-verlängernder Medikamente exponentiell größer. Dieser Artikel zeigt, welche Mechanismen hinter der Erkrankung stecken und wie das Risiko für potenziell tödliche Rhythmusstörungen gesenkt werden kann. Publication Date: 08 December 2020 (online) © 2020. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany


  • Open Access

    Circulating MicroRNA-21 Correlates With Left Atrial Low-Voltage Areas and Is Associated With Procedure Outcome in Patients Undergoing Atrial Fibrillation Ablation

    by Qifeng Zhou, Carole Maleck, Saskia N.I. von Ungern-Sternberg, Balram Neupane, David Heinzmann, Jonathan Marquardt, Martin Duckheim, Christian Scheckenbach, Fabian Stimpfle, Meinrad Gawaz, et al.

    Background: Atrial fibrosis is a hallmark of arrhythmogenic structural remodeling in patients with persistent atrial fibrillation (AF) and is negatively correlated with procedure outcome in patients undergoing ablation. However, noninvasive methods to determine the extent of atrial fibrosis are limited. Here, we used microRNA (miRNA) expression analysis to detect markers of left atrial low-voltage areas (LVAs) in patients with persistent AF undergoing catheter ablation. Methods: We performed 3-dimensional voltage mapping in 102 patients (average age 62.1±13.1 years, CHA 2 DS 2 -VASc score of 2.3±1.6, LA size 41.5±5.7 mm) undergoing ablation for persistent AF and determined the extent of left atrial low-voltage. LVAs were defined if bipolar electrogram amplitudes were <0.5 mV during sinus rhythm. Before ablation, we obtained a blood sample, isolated miRNAs, and profiled them on a miRCURY LNA Universal RT microRNA PCR Human panel. Results: Sixty-nine miRNAs were identified in all samples, with an average of 123 miRNAs detectable per sample. We found that the serum concentration of miR-21, a miRNA that has been previously linked to cardiac fibrosis development, was strongly associated with the extent of LVAs determined by voltage mapping. We could confirm that LVAs were negatively correlated with ablation success in a 1-year follow-up. In addition, miR-21 serum levels were associated with AF-free survival after catheter ablation. Conclusions: Circulating miR-21 correlates with left atrial LVAs and is associated with procedure outcome in patients with persistent AF undergoing ablation.